ZR4-23272-44974
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 782 / TX
- Registered
- 2021-05-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-17
Registered in v-safe
-
2021-05-17
Dose 1 — Pfizer-BioNTech
- 2021-05-17
-
2021-05-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-05-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-05-21
-
2021-05-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-05-23
-
2021-05-25
Survey response — day 7, dose 1MedDRA: Dysgeusia, Parosmia — Feeling: Poor · Headache, Fatigue or tiredness, Abdominal painFree text: Metallic/butter taste in nose and mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-31
-
2021-06-07
Dose 2 — Pfizer-BioNTech
- 2021-06-07
-
2021-06-08
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaFree text: Metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-09
- 2021-06-10
-
2021-06-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-06-13
- 2021-06-14
- 2021-06-21
- 2021-06-30
- 2021-07-07
- 2021-07-12
- 2021-07-19
- 2021-09-06
- 2021-12-07
-
2022-01-01
Dose 3 — Moderna
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, DiarrheaAdult check-in
-
2022-01-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2022-01-04
- 2022-01-05
- 2022-01-06
- 2022-01-07
-
2022-01-26
Survey response — day 21, dose 3MedDRA: Eclampsia, Pre-eclampsia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Pre-eclampsia that's turned to eclampsiMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — day 21, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-01-27
- 2022-02-07
- 2022-02-15
- 2022-04-04
- 2022-07-03
- 2023-01-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-17 | Pfizer-BioNTech | |
| 2 | 2021-06-07 | Pfizer-BioNTech | |
| 3 | 2022-01-01 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-26 | Unsuccessful |
Free text
Release 8 — day 7, dose 1
Systemic reaction (other): Metallic/butter taste in nose and mouth
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Metallic taste in mouth
Release 11 — day 21, dose 3
Symptoms: Pre-eclampsia that's turned to eclampsi
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eclampsia | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Parosmia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release